~~<i id='C03A0E576B'><strike id='C03A0E576B'><tt id='C03A0E576B'><pre id='C03A0E576B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：leisure time 2025-10-02 23:45:15 - browse：667

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： J&J to buy cancer drug developer Ambrx Biopharma

leisure time

Wikipedia

hotspot

focus

entertainment

hotspot

AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b

WSS

The FDA must approve intranasal treatments for anaphylaxis

Abortion pill case raises question: who can sue the FDA?

Merck drug for rare lung condition set for approval in U.S.

Chronically ill young patients struggle to find fertility info

New weight loss drugs work. But how can they best be used?

Goldman Sachs launches $650M fund for life science investments

hotspot

entertainment

leisure time

Medicare details structure of new drug price negotiation program

States should stop sabotaging methadone treatment reform

Jerome Adams on the need for new antivirals for Covid

JPM: CVS says Medicare Advantage patients are impacting profits

United colonoscopy coverage change 'may cost lives,' doctors say

Chronically ill young patients struggle to find fertility info

DIEP, the 'gold standard' of breast reconstruction, is under threat

UCB departs biotech trade group BIO

New air purifier tech could be key to improving indoor air quality

Eliminate the waiting period for sterilization covered by Medicaid

Wikipedia

Supreme Court mifepristone arguments center on docs' right to sue

Why the world’s most expensive drug might be worth the price

JPM: CVS says Medicare Advantage patients are impacting profits

Primary care physicians play key roles in Alzheimer's management

The biotech scorecard for Q1: 17 stock

Antibiotic resistance and the global rise in human conflict

hotspot

focus

entertainment

hotspot